O4‐04‐05: Aducanumab (BIIB037), an anti‐amyloid beta monoclonal antibody, in patients with prodromal or mild Alzheimer's disease: Interim results of a randomized, double‐blind, placebo‐controlled, phase 1b study
Year: 2015
Type: article
Study design: Clinical Trial
Source: Alzheimer s & Dementia
Authors: Jeff Sevigny, Ping Chiao, Leslie Williams, Tianle Chen, Yan Ling, John O'Gorman, Christoph Hock, Roger M. Nitsch, Alfred Sandrock
Institutions: Biogen (United States), University of Zurich
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keyword: aducanumab
Open Access status: closed
OpenAlex ID: W2337565256
